Schizophrenia - Recent Advances and Patient-Centered Treatment Perspectives

Abstract

specializing in neuropharmacology. She has worked at Eli Lilly and Company, Indianapolis, USA and has a clinical practice that offers brain mapping and applied behavior analysis (ABA), Indiana Brain Mapping. Her research is on the brain circuit that underlies neurological disorders including depression, autism, and schizophrenia. Although trained in drug development, she has pioneered cutting-edge applications to the treatment of mental disorders from both neurobiology and behavioral science and uses natural environment modification as a treatment approach. She pioneered the use of portable brain imaging to guide behavior treatment for various mental disorders, including schizophrenia. As a member of ABAI and an NGO member of the United Nations, she works on outreach projects in Asia to advance the Universal Declaration of Human Rights, aiming to promote better recognition of individuals with mental disabilities, including schizophrenia. Her overarching aim to is advance treatment intervention, and apply innovative brain-mapping technology to help the public understand mental disorders.